You just read:

Interpace Diagnostics Enters into Collaborative Agreement with Viatar CTC Solutions to Detect and Characterize Early Cancer in Liquid Biopsies

News provided by

Interpace Diagnostics Group, Inc.

Feb 21, 2017, 08:00 ET